These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 11457513)
1. Regulation of cholecystokinin release from central nerve terminals. Ghijsen WE; Leenders AG; Wiegant VM Peptides; 2001 Aug; 22(8):1213-21. PubMed ID: 11457513 [TBL] [Abstract][Full Text] [Related]
2. Release of cholecystokinin in the central nervous system. Raiteri M; Paudice P; Vallebuona F Neurochem Int; 1993 Jun; 22(6):519-27. PubMed ID: 8513278 [TBL] [Abstract][Full Text] [Related]
3. Localization and opiate receptor binding of enkephalin, CCK and ACTH/beta-endorphin in the rat central nervous system. Stengaard-Pedersen K; Larsson LI Peptides; 1981; 2 Suppl 1():3-19. PubMed ID: 6267560 [TBL] [Abstract][Full Text] [Related]
4. Differential surface density and modulatory effects of presynaptic GABA Booker SA; Althof D; Degro CE; Watanabe M; Kulik Á; Vida I Brain Struct Funct; 2017 Nov; 222(8):3677-3690. PubMed ID: 28466358 [TBL] [Abstract][Full Text] [Related]
8. [Is cholecystokinin a biological support in panic attacks?]. Bourin M; Bradwejn J; Koszycki D Encephale; 1991; 17(5):475-9. PubMed ID: 1686250 [TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin directly inhibits neuronal activity of primary gonadotropin-releasing hormone cells through cholecystokinin-1 receptor. Giacobini P; Wray S Endocrinology; 2007 Jan; 148(1):63-71. PubMed ID: 17023535 [TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin and vasoactive intestinal polypeptide in the mammalian CNS: distribution and possible physiological roles. Emson PC; Hunt SP; Rehfeld JF; Golterman N; Fahrenkrug J Adv Biochem Psychopharmacol; 1980; 22():63-74. PubMed ID: 6994447 [No Abstract] [Full Text] [Related]
11. Cholecystokinins in the central nervous system and neurohypophysis. Vanderhaeghen JJ; Lotstra F; Vierendeels G; Gilles C; Deschepper C; Verbanck P Peptides; 1981; 2 Suppl 2():81-8. PubMed ID: 6283501 [TBL] [Abstract][Full Text] [Related]
12. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum. Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594 [TBL] [Abstract][Full Text] [Related]
13. Binding of cholecystokinin, bombesin and muscarine to neurons and astrocytes in explant cultures of rat central nervous system: autoradiographic and immunohistochemical studies. Hösli E; Hösli L Neuroscience; 1994 Jul; 61(1):63-72. PubMed ID: 7969896 [TBL] [Abstract][Full Text] [Related]
14. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors. Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470 [TBL] [Abstract][Full Text] [Related]
19. Minireview. The ascent of cholecystokinin (CCK) - from gut to brain. Morley JE Life Sci; 1982 Feb; 30(6):479-93. PubMed ID: 6122154 [No Abstract] [Full Text] [Related]
20. Cholecystokinin and learning and memory processes. Hadjiivanova C; Belcheva S; Belcheva I Acta Physiol Pharmacol Bulg; 2003; 27(2-3):83-8. PubMed ID: 14570153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]